Table 1 Clinical characteristics of the affected eyes
| Â | Eyes with gas tamponade | Eyes with silicone oil tamponade | P value (Mann-Whitney/Fisher-Chi Square test) |
|---|---|---|---|
Age, years | 55.5 ± 9.68 | 51.5 ± 10.1 | 0.159 |
Sex | 4 M/12F | 7 M/10F | 0.465 |
Laterally | 12R/4 L | 9R/8 L | 0.282 |
Duration between symptoms and surgery, days | 18.2 ± 15.9 | 25.8 ± 19.0 | 0.168 |
Proliferative vitreoretinopathy grades, eyes | PVR A&B:8 PVR C:8 | PVR A&B:8 PVR C:9 | 1.000 |
Extension of RRD (number of clock-hours involved) | 3.7 ± 0.9 | 3.7 ± 0.7 | 0.908 |
Number of retinal tears/breaks | 1.1 ± 0.3 | 1.2 ± 0.4 | 0.685 |
Frequency of retinal breaks involving the inferior 4 clock-hours’ area | 1/17 | 4/16 | 0.335 |
Axial length, mm | 23.9 ± 0.8 | 24.1 ± 1.1 | 0.792 |
Follow-up duration, months | 36.3 ± 3.7 | 35.8 ± 3.7 | 0.698 |
LogMAR BCVA at presentation, Snellen equivalent | 0.25 ± 0.18 20/36 | 0.30 ± 0.22 20/40 | 0.509 |
IOP at presentation, mmHg | 12.5 ± 2.6 | 13.6 ± 2.5 | 0.171 |
LogMAR BCVA at the follow-up, Snellen equivalent | 0.17 ± 0.23 20/30 | 0.49 ± 0.28 20/62 | < 0.001 |
IOP at the follow-up | 16.5 ± 3.2 | 18.6 ± 4.7 | 0.191 |